- Home
- CISO vs ALBT Comparison
CISO vs ALBT Comparison
Compare CISO & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- ALBT
- Stock Information
- Founded
- CISO 2015
- ALBT 2014
- Country
- CISO United States
- ALBT United States
- Employees
- CISO N/A
- ALBT N/A
- Industry
- CISO Computer Software: Prepackaged Software
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CISO Technology
- ALBT Health Care
- Exchange
- CISO Nasdaq
- ALBT Nasdaq
- Market Cap
- CISO 8.3M
- ALBT 2.9M
- IPO Year
- CISO N/A
- ALBT N/A
- Fundamental
- Price
- CISO $0.88
- ALBT $0.20
- Analyst Decision
- CISO
- ALBT
- Analyst Count
- CISO 0
- ALBT 0
- Target Price
- CISO N/A
- ALBT N/A
- AVG Volume (30 Days)
- CISO 99.5K
- ALBT 633.7K
- Earning Date
- CISO 11-11-2024
- ALBT 11-12-2024
- Dividend Yield
- CISO N/A
- ALBT N/A
- EPS Growth
- CISO N/A
- ALBT N/A
- EPS
- CISO N/A
- ALBT N/A
- Revenue
- CISO $55,807,138.00
- ALBT N/A
- Revenue This Year
- CISO $78.76
- ALBT N/A
- Revenue Next Year
- CISO N/A
- ALBT N/A
- P/E Ratio
- CISO N/A
- ALBT N/A
- Revenue Growth
- CISO 29.55
- ALBT N/A
- 52 Week Low
- CISO $0.26
- ALBT $0.16
- 52 Week High
- CISO $3.60
- ALBT $1.44
- Technical
- Relative Strength Index (RSI)
- CISO 57.14
- ALBT 43.14
- Support Level
- CISO $0.77
- ALBT $0.16
- Resistance Level
- CISO $1.08
- ALBT $0.22
- Average True Range (ATR)
- CISO 0.12
- ALBT 0.03
- MACD
- CISO -0.01
- ALBT 0.00
- Stochastic Oscillator
- CISO 53.55
- ALBT 27.54
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.